Marcin Szumowski

Molecure

Marcin graduated from the University of Illinois with PhD & MBA degrees. He is a life science entrepreneur and investor. Medicalgorithmics, where he was the co-founding CEO, was the first Polish company to introduce an FDA-approved cardiac telemetry solution to the US and global markets. During the last 20 years, he managed over 40 R&D and investment projects with a combined budget of over a quarter billion EUR. Marcin co-founded and has been the lead investor in an early-stage seed fund Life Science Innovations (LSI) with a portfolio of 11 innovative life science companies and 2 successful exits. He was a member of the GLG Institute and participated in the European Commission's expert panels evaluating the Innovative Medicines Initiative (IMI), the world's largest public-private partnership (PPP) in pharmaceutical research.